CARsgen’s Satri-cel NDA Accepted by China’s NMPA for Gastric Adenocarcinoma
China-based CARsgen Therapeutics Holdings Ltd (HKG: 2171) announced that the National Medical Products Administration (NMPA)...
Lepu Biopharma Gains EMA Approval for MRG003 HNSCC Clinical Trial
China-based Lepu Biopharma Co., Ltd (HKG: 2157) announced that it has received approval from the...
RemeGen Inks Global Licensing Pact With Vor Biopharma for Telitacicept
China-based RemeGen Co., Ltd. (SHA: 688331, HKG: 9995) announced an exclusive licensing agreement with U.S.-based...
Angel Pharma Gains NMPA Approval for Soquelitinib in Atopic Dermatitis Trial
China-based Angel Pharmaceuticals Ltd announced that it has received approval from the National Medical Products...
Biogen’s Phase I Results Highlight Salanersen’s Potential in Spinal Muscular Atrophy
Biogen (NASDAQ: BIIB) announced this week topline results from the Phase I study of salanersen...
Kymera and Sanofi Advance IRAK4 Program With Selection of KT-485 for Clinical Development
US-based Kymera Therapeutics Inc. (NASDAQ: KYMR) announced updates to its IRAK4-targeted program collaboration with Sanofi....
LG Chem’s Cross-Linked Sodium Hyaluronate Gel Gains NMPA Approval for Midface Use
South Korea’s LG Chem announced that its cross-linked sodium hyaluronate gel with lidocaine has received...
Porton Advanced Partners With EVA Pharma to Boost CAR-T Cell Therapy in MENA
China-based Contract Development and Manufacturing Organization (CDMO) Porton Advanced Solutions Ltd. has entered into a...
Eli Lilly’s Amyvid Sees FDA-Approved Label Update for Alzheimer’s Diagnosis
US-based Eli Lilly & Co. (NYSE: LLY) announced the US Food and Drug Administration (FDA)...
Gilead Signs Licensing Pact With Kymera Therapeutics for CDK2-Targeted MGD
US major Gilead Sciences, Inc. (NASDAQ: GILD) this week entered into an exclusive option and...
SineuGene’s ALS Gene Therapy SNUG01 Granted FDA Orphan Drug Designation
Beijing-based SineuGene Therapeutics, a developer of gene therapies for brain disorders, announced this week that...
Acotec Scientific Wins NMPA Approval for Armoni-HP Balloon Catheter
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that it has received marketing approval from...
Immvira Bioscience Files for Hong Kong IPO to Advance Oncolytic Immunotherapy Pipeline
Shenzhen-based Immvira Bioscience Inc. has filed for an initial public offering (IPO) with the Hong...
Genevector’s JWK002 Gains NMPA IND Approval for XLRS Gene Therapy
China-based Chengdu Geneector Biotechnology Co., Ltd. (Genevector), a developer of AAV gene therapy drugs, announced...
CMS Plans Secondary Listing on Singapore Exchange to Enhance Shareholder Base and Liquidity
China Medical System Holdings Ltd (CMS; HKG: 0867) announced its proposal for a secondary listing...
Livzon’s YJH-012 siRNA Drug Gets NMPA Green Light for Gout Trials
China-based Livzon Pharmaceutical Group Inc., (HKG: 1513) announced that its Category 1 chemical drug YJH-012...
GE Healthcare Wins FDA Approval for Vizamyl Label Update in Alzheimer’s Detection
US medical device and life sciences giant GE Healthcare Technologies Inc., (NASDAQ: GEHC) announced that...
NHSA Emphasizes Management of Designated Medical Institutions for Healthcare Quality
The National Healthcare Security Administration (NHSA) this week released a notification emphasizing the importance of...
Suzhou Porton Biologics Partners with Future Biotechnology to Expand Viral Vector Services
China-based Contract Development and Manufacturing Organization (CDMO) Suzhou Porton Biologics Ltd announced this week a...
Lundbeck’s Lu AG13909 Wins Orphan Drug Designations for Congenital Adrenal Hyperplasia
Denmark-based pharmaceutical company Lundbeck A/S (OTCMKTS: HLUBF) announced that it has received Orphan Drug Designations...